Author:
Alarfaj Sumaiah J.,Alzahrani Abdullah,Alotaibi Anfal,Almutairi Malak,Hakami Mashael,Alhomaid Njood,Alharthi Noori,Korayem Ghazwa B.,Alghamdi Abdullah
Funder
Princess Nourah Bint Abdulrahman University
Subject
Pharmaceutical Science,Pharmacology
Reference25 articles.
1. AASLD / IDSA, 2021. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. AASLD/IDSA. Aasld-Idsa.
2. Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection;Ahmed;Drug Resist. Infect.,2018
3. SASLT guidelines: Update in treatment of Hepatitis C virus infection;Alghamdi;Saudi J. Gastroenterol.,2016
4. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift;Aljumah;Saudi J. Gastroenterol.,2016
5. Update on the management and treatment of viral hepatitis;Almeida;World J. Gastroenterol.,2021
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献